COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB COMPARED TO CURRENT BIOLOGICS SEQUENCES FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN FRANCE

被引：0
|
作者：
Duteil, E. [1 ]
Cariou, C. [1 ]
Schmidt, A. [2 ]
Benjamin, K. [1 ]
Duco, J. [1 ]
机构：
[1] Novartis Pharmaceut, Rueil Malmaison, France
[2] Steve Consultants, Oullins, France
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1395
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY80
引用
收藏
页码：A589 / A589
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF SECUKINUMAB IN MODERATE TO SEVERE PSORIASIS COMPARED WITH OTHER BIOLOGICS IN GERMANY
    Graham, C. N.
    McBride, D.
    Miles, L.
    Gilloteau, I
    O'Neill, C. B.
    Neidhardt, K.
    Augustin, M.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A157 - A157
  • [2] COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB COMPARED TO USTEKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN THE CZECH REPUBLIC
    Klimes, J.
    Mollon, P.
    Graham, C.
    Rajnoch, J.
    Dostal, F.
    Skalicky, D.
    Jordan, P.
    Depta, J.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A424 - A424
  • [3] Cost-effectiveness of secukinumab as first biologic treatment, compared with other biologics, for moderate to severe psoriasis in Germany
    Augustin, M.
    McBride, D.
    Gilloteau, I.
    O'Neill, C.
    Neidhardt, K.
    Graham, C. N.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (12) : 2191 - 2199
  • [4] Cost-effectiveness of secukinumab compared with ustekinumab and etanercept for the treatment of moderate-to-severe plaque psoriasis in Greece
    Tzanetakos, C.
    Kourlaba, G.
    Hatzikou, M.
    Antoniou, C.
    Ioannides, D.
    Lefaki, I.
    Petridis, A.
    Rigopoulos, D.
    Roussaki-Schulze, V.
    Sotiriadis, D.
    Maniadakis, N.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 61 - 62
  • [5] COST-EFFECTIVENESS OF SECUKINUMAB COMPARED WITH USTEKINUMAB AND ETANERCEPT FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN GREECE
    Tzanetakos, C.
    Kourlaba, G.
    Chatzikou, M.
    Antoniou, C.
    Ioannidis, D.
    Lefaki, I
    Petridis, A.
    Rigopoulos, D.
    Roussaki-Schulze, A.
    Sotiriadis, D.
    Maniadakis, N.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A569 - A569
  • [6] A COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB 300 MG VS CURRENT THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN ITALY
    D'Ausilio, A.
    Aiello, A.
    Daniel, F.
    Graham, C.
    Roccia, A.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A424 - A424
  • [7] Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective
    Zhang, Jinsui
    Xia, Zemin
    Guo, Wanjie
    Ren, Xiaoxiao
    Liu, Fang
    Ratnaparkhi, Gargi
    Pagada, Amit
    Subramanian, Subhashini
    Hu, Min
    Chen, Wen
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2681 - 2696
  • [8] Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective
    Jinsui Zhang
    Zemin Xia
    Wanjie Guo
    Xiaoxiao Ren
    Fang Liu
    Gargi Ratnaparkhi
    Amit Pagada
    Subhashini Subramanian
    Min Hu
    Wen Chen
    [J]. Dermatology and Therapy, 2023, 13 : 2681 - 2696
  • [9] COST-EFFECTIVENES OF SECUKINUMAB COMPARED TO CURRENT TREATMENTS FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN CANADA
    Lee, A.
    Gregory, V
    Gu, Q.
    Becker, D. L.
    Barbeau, M.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A182 - A182
  • [10] COST PER RESPONDER OF SECUKINUMAB COMPARED TO OTHER BIOLOGICS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS IN BRAZIL
    Suzuki, C.
    Lopes, N.
    Tozato, C.
    Gilloteau, I
    Graham, C. N.
    [J]. VALUE IN HEALTH, 2018, 21 : S240 - S240
12345